Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhwen Soo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|July 10, 2007
Interim treatment selection using the normal approximation approach in clinical trialsZhenming Shun, K K Gordon Lan, Yuhwen Soo
Journal of Biopharmaceutical Statistics|July 19, 2005
The use of weighted Z-tests in medical researchK K Gordon Lan, Yuhwen Soo, Cynthia Siu, et al.
Ophthalmology|February 3, 2016
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 ProgramDiana V Do, Quan Dong Nguyen, Robert Vitti, et al.
Clinical Therapeutics|October 4, 2012
Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension studyHal M Hoffman, Martin L Throne, Niran J Amar, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 TrialsDarius M Moshfeghi, Seenu M Hariprasad, Jeffrey L Marx, et al.
Ophthalmology. Retina|May 4, 2019
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID StudiesDante Pieramici, Rishi P Singh, Andrea Gibson, et al.
Arthritis and Rheumatism|January 7, 2012
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trialH Ralph Schumacher, John S Sundy, Robert Terkeltaub, et al.
Ophthalmology|September 25, 2016
ReplyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT StudyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|July 10, 2007
Interim treatment selection using the normal approximation approach in clinical trialsZhenming Shun, K K Gordon Lan, Yuhwen Soo
Journal of Biopharmaceutical Statistics|July 19, 2005
The use of weighted Z-tests in medical researchK K Gordon Lan, Yuhwen Soo, Cynthia Siu, et al.
Ophthalmology|February 3, 2016
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 ProgramDiana V Do, Quan Dong Nguyen, Robert Vitti, et al.
Clinical Therapeutics|October 4, 2012
Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension studyHal M Hoffman, Martin L Throne, Niran J Amar, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 18, 2016
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 TrialsDarius M Moshfeghi, Seenu M Hariprasad, Jeffrey L Marx, et al.
Ophthalmology. Retina|May 4, 2019
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID StudiesDante Pieramici, Rishi P Singh, Andrea Gibson, et al.
Arthritis and Rheumatism|January 7, 2012
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trialH Ralph Schumacher, John S Sundy, Robert Terkeltaub, et al.
Ophthalmology|September 25, 2016
ReplyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT StudyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Pageof 3